CDT Equity Inc. Warrant

CDT Equity (NASDAQ:CDT) shares rose 14.71% to $4.68 on Monday despite the health care sector declining 2.63% over the past 30 days. The rally comes after the biopharmaceutical company disclosed a widened net loss of $39.1 million for 2025 and filed a non-timely 10K. Technical analysis shows the stock trading 49.1% below its 20-day moving average ...

CDT Equity Inc. (NASDAQ:CDT) announced multiple strategic initiatives to enhance shareholder value, including its 20% equity stake acquisition in Sarborg AI for $115 million, continued development of its pharmaceutical portfolio with AstraZeneca-licensed assets, and evaluation of capital markets initiatives to strengthen financial flexibility.